WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke EVERSANA wurde als Wortmarke am 16.01.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1495984 |
| Länder | 
|
| Basismarke |
Nr. 88054633,
26. Juli 2018
|
| Anmeldedatum | 16. Januar 2019 |
| Ablaufdatum | 16. Januar 2029 |
Markeninhaber
190 N Milwaukee St
Milwaukee WI 53202
US
Milwaukee WI 53202
US
Markenvertreter
Saul Ewing LLP,
33 South Sixth Street, Suite 4750
US
Waren und Dienstleistungen
35
Business consultation services in the health care and
biopharma industry; market research services, for drug
companies, biologic companies, medical device companies, or
other companies in the healthcare field; clinical trial
referral services, namely, posting of clinical trial notices
for the purpose of recruiting patients for participation in
clinical trials for the testing of drugs; call-center
support services, namely, operation of telephone call
centers for others; business services provided to the life
sciences, biopharmaceutical, and medical technology
industries, namely, reporting and collecting
biopharmaceutical and medical technology product complaints;
business consulting services in the life sciences field;
business management services in the healthcare field; import
and export agency services; providing advertising, marketing
and promotional services for the pharmaceutical and medical
industry; operation of telephone call centers for others in
the field of pharmaceutical, biotechnology, medical devices
and healthcare manufactures; providing information as to the
availability of pharmaceutical, biotechnology, medical
devices, healthcare and life sciences goods and services for
purchase via an online database; patient relationship
management services; advertising, promotion, and marketing
services for the pharmaceutical, biotech and medical
industries; pharmaceutical services, namely, processing
online and telephone prescription orders in specialty
pharmacies; pharmaceutical cost management services and drug
utilization review services; mail order pharmacy services;
business consulting services in the life sciences field;
business management services in the life sciences field;
providing trade information in the field of pharmaceutical,
biotechnology and healthcare manufacturer product pricing,
reimbursement data and assistance, and management of copays,
via an on-line computer database; providing business
intelligence in the fields of medical devices,
pharmaceuticals and life sciences, via an online database;
patient assistance program support services, namely,
customer service management for others; retail and specialty
retail pharmacy services; maintaining patient medical
records and files
36
Financial services, namely, financial analysis and payer
reimbursement, namely, reimbursement payment processing in
the field of biopharmaceutical and medical technology
products claims; providing insurance information about
patient healthcare benefit verification services, patient
reimbursement and insurance coverage for pharmaceuticals and
medical devices, via a website; medical insurance case and
utilization review and insurance claims adjustment services
for healthcare purchasers and payors; online information
services, namely, providing information on insurance
formulary coverage changes provided by healthcare companies
to external stakeholders such as healthcare providers and
patients, and receiving input about insurance plan formulary
coverage or policy changes from a user via an online portal
and populating pre-existing templates of materials for
external audiences; providing insurance information and
statistics about patient reimbursement and insurance
coverage for pharmaceuticals and medical devices, via an
online computer database; financial administration of
patient reimbursement programs; financial administration of
pharmacy reimbursement programs and services; insurance
management services relating to pharmaceuticals
38
Communications services, namely, transmission of voice,
audio, visual images and data by telecommunications
networks, wireless communication networks, the Internet,
information services networks and data networks in the field
of managed healthcare markets; electronic data interchange
services in the field of healthcare transactions such as
claims, eligibility, claim status, electronic remittance
advice, prior authorizations, attachments and referrals that
allow direct transaction and payment communications between
healthcare providers and payers
39
Supply chain services, namely, warehousing and
transportation and delivery of goods for others by air,
rail, ship, truck; pharmacy packaging services; reverse
logistics packaging services
42
Research and testing services in the field of
pharmaceutical, biotechnology, medical devices and
healthcare; medical research; conducting clinical trials for
others in the life sciences, biopharmaceutical, and medical
technology fields; hosting a website featuring technology to
allow users to determine a patient's healthcare benefit
verification services, a patient's prescription medication
co-payment, to process insurance company approvals and to
verify prescription medication; computer software
consultancy rendered to pharmaceutical companies in the
field of drug pricing and medical device pricing; providing
a web hosting platform for hosting virtual advisory boards,
speaker trainings and peer-to-peer programs for stakeholders
in the health care community, namely, medical and
pharmaceutical suppliers, healthcare professionals and payer
representatives
44
Consulting services in the field of healthcare for
pharmaceutical, biotechnology and healthcare manufactures;
health care services, namely, managed health care services;
pharmaceutical advice; dispensing pharmaceuticals; providing
information to patients in the field of administering
medications; provision of healthcare information in the
field of physician groups services, health systems and
hospitals, HMOs [Health Maintenance Organizations] and
insurance providers, regional market data, drug product and
customer response data; patient support services and patient
advocacy services, namely, providing health care information
by telephone; patient support services, namely, medical
consultations provided via phone, online chat or
videoconferencing; patient support services and patient
advocacy services, namely, consulting services in the field
of health; providing health care management services for
coordinating medical, physical, social, personal care and
psychological assistance in the field of health care, acute
and chronic disease management, long-term care, cancer
treatment, and medical treatment; providing health care
management services for coordinating the procurement and
administration of medication (terms considered too vague by
the International Bureau - Rule 13(2)(b) of the Common
Regulations)
45
Providing licensing, regulatory, and compliance services,
namely, licensing of intellectual property, regulatory
compliance consulting in the life sciences,
biopharmaceutical, and medical technology fields, reviewing
standards and practices to assure compliance with food and
drug industry laws and regulations; providing patient
advocate services to hospital patients and patients in long
term care facilities; providing patient advocate services to
individuals in need of medical and health care services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 02. Dezember 2021 | 2021/49 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 09. Juni 2021 | 2021/23 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 04. Februar 2021 | 2021/5 Gaz | JP | Ablehnung |
| 06. Januar 2021 | 2021/4 Gaz | CH | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 01. Oktober 2020 | 2020/41 Gaz | CH | Ablehnung |
| 30. September 2020 | 2020/45 Gaz | US | RAW: Partial Ceasing Effect |
| 13. September 2020 | 2020/43 Gaz | SG | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 24. August 2020 | 2020/35 Gaz | IN | Ablehnung |
| 19. August 2020 | 2020/34 Gaz | KR | Ablehnung |
| 12. Juni 2020 | 2020/29 Gaz | EM | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 22. April 2020 | 2020/17 Gaz | AU | Ablehnung |
| 22. Januar 2020 | 2020/5 Gaz | CN | Ablehnung |
| 29. November 2019 | 2019/49 Gaz | SG | Ablehnung |
| 08. November 2019 | 2019/47 Gaz | EM | Ablehnung |
| 16. Januar 2019 | 2019/42 Gaz | US | Eintragung |
ID: 141495984